Status:
COMPLETED
Office Hysteroscopy in Women Using Progesterone-only Contraception (POC)
Lead Sponsor:
Woman's Health University Hospital, Egypt
Conditions:
Fallopian Tube Peristalsis and Patency
Endometrial Pattern
Eligibility:
FEMALE
20-40 years
Brief Summary
Mechanisms of action of progesterone-only contraception (POC) include endometrial and Fallopian tubal changes without any scientific documentation. We succeeded to document proper assessment of the pr...
Detailed Description
progesterone-only contraception (POC) prevent pregnancy by thickening the mucus in the cervix to stop sperm reaching an egg and assumed to increase Fallopian tubal motility so the fertilized oocyte re...
Eligibility Criteria
Inclusion
- women using progesterone-only contraception (POC)
- women planned for office hysteroscopy for other indication.
Exclusion
- A suspected pregnancy.
- heavy vaginal bleeding.
- active pelvic inflammatory disease (PID).
- severe co-morbidity, e.g., severe cardiac, neurologic, or chest disease
- Other medical contraindications to pregnancy
Key Trial Info
Start Date :
August 3 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2023
Estimated Enrollment :
146 Patients enrolled
Trial Details
Trial ID
NCT04368104
Start Date
August 3 2021
End Date
July 1 2023
Last Update
July 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Woman's Health University Hospital
Asyut, Egypt, 71111